Skip to main content

Beckman Coulter Genomics, Genpathway Partner to Provide ChIP-seq Service


Beckman Coulter Genomics and Genpathway are partnering to provide customers with whole-genome chromatin immunoprecipitation sequencing services, the companies said this week.

The new service, which is available worldwide, expands the DNA sequencing applications portfolio of Beckman Coulter Genomics, headquartered in Danvers, Mass.

Taking advantage of Genpathway's experience with ChIP, the service includes experimental design, antibody qualification, ChIP assays, next-generation sequencing, and data analysis.

Beckman Coulter Genomics, which provides genomic services as well as nucleic acid purification products, resulted from a merger of Beckman Coulter's Agencourt Biosciences with Cogenics last year.

Genpathway is an early-stage pharmacogenomics company providing drug and biomarker discovery and development services. The company uses a proprietary ChIP technology to understand gene regulation and genetic pathways.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.